GIUDICE, GIULIA CLAIRE
 Distribuzione geografica
Continente #
AS - Asia 995
NA - Nord America 719
EU - Europa 484
SA - Sud America 145
AF - Africa 61
OC - Oceania 4
Totale 2.408
Nazione #
US - Stati Uniti d'America 687
SG - Singapore 403
VN - Vietnam 195
CN - Cina 172
IT - Italia 131
BR - Brasile 110
HK - Hong Kong 84
DE - Germania 76
FR - Francia 66
ZA - Sudafrica 50
NL - Olanda 46
IN - India 30
GB - Regno Unito 28
FI - Finlandia 21
JP - Giappone 19
CA - Canada 18
IE - Irlanda 18
RU - Federazione Russa 16
DK - Danimarca 14
BD - Bangladesh 13
SE - Svezia 13
AR - Argentina 12
AT - Austria 11
KR - Corea 11
EC - Ecuador 8
ID - Indonesia 8
IQ - Iraq 8
PH - Filippine 8
MY - Malesia 7
TR - Turchia 7
ES - Italia 6
MX - Messico 6
PL - Polonia 6
BE - Belgio 5
HU - Ungheria 5
PK - Pakistan 5
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
CO - Colombia 4
CZ - Repubblica Ceca 4
IR - Iran 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CL - Cile 3
CR - Costa Rica 3
MA - Marocco 3
PE - Perù 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
EG - Egitto 2
IL - Israele 2
KE - Kenya 2
LT - Lituania 2
LV - Lettonia 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
AO - Angola 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
JM - Giamaica 1
LB - Libano 1
MC - Monaco 1
PS - Palestinian Territory 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UA - Ucraina 1
YE - Yemen 1
Totale 2.408
Città #
Singapore 262
Ashburn 167
San Jose 111
Santa Clara 90
Hong Kong 76
Ho Chi Minh City 55
Hanoi 49
Johannesburg 46
Beijing 36
Munich 35
Los Angeles 33
Boardman 31
Dallas 28
New York 24
Lauterbourg 22
Marseille 20
Hefei 16
Dublin 15
Haiphong 15
Frankfurt am Main 14
Amsterdam 13
Aarhus 12
Buffalo 12
Da Nang 11
Düsseldorf 11
Milan 11
Parma 11
Shanghai 11
Montreal 10
Rome 10
Helsinki 9
Osaka 9
São Paulo 9
Chennai 8
Jinan 8
London 8
Moscow 8
Nuremberg 8
Orem 8
Tokyo 8
Turku 8
Sassuolo 7
Vienna 7
Council Bluffs 6
Naples 6
Ninh Bình 6
Paris 6
San Francisco 6
Bologna 5
Budapest 5
Cavriago 5
Denver 5
Seoul 5
Stockholm 5
Tashkent 5
Warsaw 5
Bengaluru 4
Brussels 4
Chiari 4
Kitzingen 4
Melbourne 4
Poplar 4
Portsmouth 4
Prague 4
Quito 4
Sungai Petani 4
Trento 4
Atlanta 3
Bexley 3
Brasília 3
Brooklyn 3
Buenos Aires 3
Chicago 3
City of London 3
Collecchio 3
Erbil 3
Guayaquil 3
Lahore 3
Paderno Dugnano 3
Rio de Janeiro 3
Rocca Priora 3
Solna 3
Surabaya 3
Thái Nguyên 3
Venice 3
Ankara 2
Baku 2
Bauru 2
Belo Horizonte 2
Bismarck 2
Biên Hòa 2
Cairo 2
Campo Grande 2
Can Tho 2
Casablanca 2
Columbus 2
Copenhagen 2
Dhaka 2
Dietikon 2
Gainesville 2
Totale 1.560
Nome #
LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial 265
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 147
2125P Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study 126
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma 121
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 115
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 114
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review 114
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 111
Successful treatment with selpercatinib after pralsetinib-related pneumonitis and intracranial failure in a patient with RET-rearranged nonsmall cell lung cancer 108
Potential ROle of hypovitaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): a prospective observational study. 106
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 102
Comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: is AUC close enough to clinical practice? 90
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 88
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study 88
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 83
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors 78
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 73
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study 72
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study) 72
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney 72
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project 70
Comparing a Part with the Whole: Beware of the Disparity of the Renal Cell Carcinoma Prognostic Models 68
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9) 63
Wolf in sheep's clothing or not? The pT1 LG dilemma 51
Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case report 38
Totale 2.435
Categoria #
all - tutte 8.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 0 5 0 1
2022/202319 2 1 1 0 0 1 0 0 13 0 1 0
2023/2024119 0 24 9 2 5 10 12 1 12 8 6 30
2024/2025763 14 57 56 33 58 88 44 36 65 87 73 152
2025/20261.528 160 116 193 157 247 117 170 71 184 113 0 0
Totale 2.435